Tauroursodeoxycholic Acid (TUDCA) /Pure High Quality/ISO Certified Quality/CAS 14605-22-2

• Customization: Available
• CAS No.: CAS 14605-22-2
• Formula: C26h45no6s
• Model NO.: CAS 14605-22-2
• EINECS: 1308068-626-2
• Type: Additives
• Appearance: Powder
• Quality: Nutraceuticals, Pharmaceuticals
• Colour: White
• Transport Package: 25kg/Drum
• Specification: 99%~101%
• Trademark: puyer
• Origin: China
• Production Capacity: 50000mt/Year

Product Description

Tauroursodeoxycholic Acid (TUDCA)          CAS# 14605-22-2
Description:
Tauroursodeoxycholic Acid (TUDCA) is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA. However, bears contain large amounts of TUDCA in their bile.TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.

Specification sheet

ITEMS	SPECIFICATIONS
Apperance	White or off-white crystalline powder
Assay	99%~101%
Specific optical rotation	+45.0°~+47.0°
PH	1.3~2.3
Water	6.0%~8.0%
Melting Point:	Mp 151-159ºC
Sulphated ash	≤0.1%
Loss on drying	≤1.0%
Heavy Metals	≤10.0ppm

Function
1. Cooling blood and hemostasis,clearing heat and diuresis.
2. As an effective hemostat or blood coagulant that has been used to reduce or stop hemorrhage and bleeding from internal organs, particularly controlling profuse menstruation, postpartum and uterine bleeding, and blood in the urine.
3.Can increase the amount of bile secretion, relaxation of the bile duct sphincter produce choleretic effect, is conducive to the discharge of stones.
4.It is suitable for the treatment of cholesterol-induced stones, hyperlipidemia, bile secretory diseases, primary biliary cirrhosis, chronic hepatitis, bile reflux gastritis and prevention of acute rejection and response to liver transplantation.
5.For the treatment of gallstones, primary sclerosing cholangitis, primary biliary cirrhosis and chronic hepatitis C virus.